AveXis raises $136.6M in follow-on

Gene therapy company AveXis Inc. (NASDAQ:AVXS) raised $136.6 million through the sale of 4 million shares at $34.50 in a follow-on underwritten by Goldman Sachs, Jefferies, BMO Capital Markets and Chardan. AveXis shareholder PBM Capital Investments raised $10 million through the sale of 289,855 shares in a concurrent offering.

AveXis proposed the offering after market close Tuesday, when its shares were worth $37.58. It proposed to sell 3.6 million shares, and said PBM Capital planned to sell 433,526 shares in the offering. AveXis gained $0.60 to $36.01 on Thursday. ...